the SmallCapReview mailing list.
Aurinia Pharmaceuticals: A
late-stage biopharmaceutical company providing novel products specifically
engineered to treat a limited, targeted patient population suffering from
serious disease states for which there is a high unmet medical need.
Myriad Genetics: A
personalized medicine company, that focuses on the
development and marketing of predictive, personalized, and
prognostic medicine tests worldwide.
MYGN has a collaboration with AstraZeneca for the
development of an indication for BRACAnalysis CDx.
Hispanica International: Is
engaged in the distribution of proprietary, licensed and third party
Hispanic and Ethnic food and beverages throughout the United States.
added over 1,400 retailers to now surpass 2,000 retail locations and will
expand to over 5,000 retail locations. More.
Where Small Cap Stocks Thrive Since
Cap Winners: SMIT Up 33%, DM Up 26%, MTSL Up 25%, TCP Up 25%.
Small Cap Indexes Are An Economic Barometer
Investors Are Shifting To Small Cap Stocks
Winners And 10 Losers In The Small Cap Sector.
Reasons For The Small Cap Boom.
Caps Lead Performance Year To Date.
Stocks Dominate The Battle For Highest Returns.
Best Performing Stocks In The S&P 600 Small Cap Index.
Wars Turn Small Caps Into Latest Safety Play.
Trade war fears have been driving small cap
stocks higher. Small caps rely on just 20 percent of their
sales from overseas markets, so they are more insulated from tariffs and
other retaliatory actions. Small cap stocks have been racing ahead of
large caps since February, and should continue to outperform.
Hottest Small Caps Of 2018.
Return Home As Small Caps Lead The Way.
2000 Has Posted Gains For Six Straight Weeks.
Caps Beating Large By Most In 16 Years.
Caps Are Trouncing Large Cap Rivals.
And Small Caps At All Time High.
Cap Stock Boom Spurs Most Inflows Since Trump Victory.
Small Cap Growth Stocks The New Market Leaders?
Caps To Watch.
Cap IR By The Numbers. Average
Small Cap IR budget: $224,000, with $78,000 spent on external services.
has the deepest diagnostic pipeline across the disease spectrum."
on MYGN here...
has the potential to become a best in class medication and the first
approved treatment for LN in the U.S. and Europe."
on AUPH here...
Bring Latin America And The World To You."
on HISP here...
Subscribers to our Free
newsletter will receive stock reports and news alerts for small-cap stocks
via email. You can sign-up
"A Primer In
is a leading destination for small-cap picks and news. The Purpose of
is to profile and bring awareness to companies with a market cap of
less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap
stocks to watch via various newswires. We will strive to bring you the
undiscovered, the undervalued, and the oversold.
does not give "buy" recommendations, price targets nor
suggest entry and exit points.
"A Look at Small Cap Stocks that may no longer be Small Caps"